Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Clearmind Medicine Inc. - Common Shares (NQ: CMND ) 1.560 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 18,587 Open 1.560 Bid (Size) 1.520 (5) Ask (Size) 1.600 (8) Prev. Close 1.560 Today's Range 1.560 - 1.560 52wk Range 0.9205 - 3.580 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute December 26, 2024 From Clearmind Medicine Inc. Via GlobeNewswire Why Is Penny Stock Clearmind Gaining Today? December 24, 2024 Clearmind Medicine's stock rose 63.9% after receiving IRB approval for its Phase I/IIa trial of CMND-100, a drug for alcohol use disorder. Via Benzinga Performance YTD -43.88% -43.88% 1 Month +17.29% +17.29% 3 Month +25.81% +25.81% 6 Month +16.42% +16.42% 1 Year -39.30% -39.30% More News Read More Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial December 24, 2024 From Clearmind Medicine Inc. Via GlobeNewswire Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ Format December 16, 2024 From Clearmind Medicine Inc. Via GlobeNewswire Why Aehr Test Systems Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket October 11, 2024 Via Benzinga Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site October 10, 2024 From Clearmind Medicine Inc. Via GlobeNewswire Clearmind Medicine Files International Patent For Ibogaine Combination Therapy September 17, 2024 Via Benzinga Topics Intellectual Property Exposures Intellectual Property Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy September 16, 2024 From Clearmind Medicine Inc. Via GlobeNewswire Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment September 12, 2024 From Clearmind Medicine Inc. Via GlobeNewswire SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination Treatment September 06, 2024 From SciSparc Ltd Via GlobeNewswire Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment September 06, 2024 From Clearmind Medicine Inc. Via GlobeNewswire Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment August 29, 2024 From Clearmind Medicine Inc. Via GlobeNewswire Could Psychedelics End Binge Drinking? A Breakthrough Patent Says Yes August 23, 2024 Via Benzinga Topics Intellectual Property Exposures Intellectual Property Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment August 21, 2024 From Clearmind Medicine Inc. Via GlobeNewswire Clearmind Medicine and Yissum Expand Collaboration with International Patent Application for Generation 3.0 Psychedelic Compounds to Treat Mental Disorders August 16, 2024 From Clearmind Medicine Inc. Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday August 09, 2024 Via InvestorPlace Why Doximity Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket August 09, 2024 Via Benzinga Clearmind Medicine: New Scientific Publication Shows MEAI's Potential as a Novel Weight Loss Drug August 06, 2024 From Clearmind Medicine Inc. Via GlobeNewswire SciSparc’s Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article Showing MEAI Potential as a Novel Weight Loss Drug August 06, 2024 From SciSparc Ltd Via GlobeNewswire Clearmind Medicine Concludes the Successful Participation in the Psychedelic Medicine – Israel 2024 Conference: Presented Industry Leaders its Groundbreaking Research July 31, 2024 From Clearmind Medicine Inc. Via GlobeNewswire Clearmind Medicine Signs an Agreement to Source Manufacturers and Distributors for its Alcohol Substitute Beverage Product July 19, 2024 From Clearmind Medicine Inc. Via GlobeNewswire Nasdaq Edges Lower; Morgan Stanley Earnings Top Views July 16, 2024 Via Benzinga Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 16, 2024 Via Benzinga Crude Oil Down 1%; Bank of America Posts Upbeat Earnings July 16, 2024 Via Benzinga Exposures Fossil Fuels Why Is SciSparc (SPRC) Stock Up 25% Today? July 16, 2024 Via InvestorPlace Topics Intellectual Property Exposures Intellectual Property Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
